Skip to main content

Establishment profile

GILEAD SCIENCES

333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404
Operated by GILEAD SCIENCES, INC · 1 of 5 establishments
325411Medicinal and Botanical Manufacturing

Download as PDF →

OSHA inspections
3
over 26 years
Violations
5
$5,700 in penalties
Penalties
$5,700
$1,140 avg
Violations across 2 federal agencies
Enforcement actions from multiple agencies may indicate systemic compliance issues across functions.
Accident investigations on record
1 hospitalizations

Summary

GILEAD SCIENCES has accumulated 5 OSHA violations across 3 inspections over 26 years of recorded history, with $5,700 in total assessed penalties.

The establishment sits in the 68th percentile for violations within its industry-state peer group of 228 employers. Inspection frequency runs at the 88th percentile. The most recent enforcement activity was recorded 16 years ago.

Federal records were found in 2 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

GILEAD SCIENCES appears in OSHA workplace safety, EPA environmental compliance, NLRB labor relations, and OFLC visa and labor certification (historical) records only. No matching records were found in WHD wage enforcement, MSHA mine safety, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, CPSC product recalls, or NHTSA vehicle recalls.

OSHA workplace safety

Inspections
3
0.1 / yr · last 26 yrs
Violations
5
0.2 / yr
Penalties
$5,700
$1,140 avg / violation
40% serious60% other
Inspection trigger · accident
2 of 3

67% of inspections at this establishment produced violations,

Peer comparison

68th

Above average violations in NAICS 3254 within CA. Peer group: 228 employers. This establishment has 5 OSHA violations; peer median is 3.

Fewer violationsMore violations
Penalty percentile
72nd
peer median: $1,575
Inspection frequency
88th
peer median: 1

Safety self-report (OSHA 300A)

No self-reported injury rates filed with OSHA's Injury Tracking Application for GILEAD SCIENCES. Verify directly with OSHA Injury Tracking Application

Industry benchmark

Industry avg TRIR
1.4
BLS SOII 2024
Industry avg DART
1.0
BLS SOII 2024
Self-reported TRIR
Not in OSHA ITA

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

Inspection breakdown

Accident
2

Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.

OSHA severe injury reports

No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for GILEAD SCIENCES. Verify directly with Occupational Safety and Health Administration

OSHA accident events

Accidents, fatalities, and catastrophes documented during OSHA inspections at this employer. Each entry links to the inspection that recorded it.

DateEventInjuriesHospitalizedFatalities
Jul 25, 2009INHALATION,CHEMICAL VAPOR,CHEMICAL1
Nov 12, 1999VAPOR,INHALATION,CHEMICAL11

Source: OSHA accident investigations. Narratives are recorded by the inspecting officer and may be truncated.

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
16 years ago

No federal enforcement activity has been recorded against this establishment in 16+ years. Most recent activity: 16 years ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for GILEAD SCIENCES. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for GILEAD SCIENCES. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

Company-level in CA — for GILEAD SCIENCES, INC, not this location alone

Total cases
1
Unfair labor practice
1

National Labor Relations Board — unfair labor practice charges and union representation cases. The NLRB records cases at the company/regional level (no worksite address), so these are matched by company name and state and may span other GILEAD SCIENCES, INC locations in the same state.

NLRB cases

National Labor Relations Board cases involving this employer. Includes unfair labor practice (ULP) filings and representation election proceedings. NLRB enforcement is process-driven; no per-case monetary penalty is assessed (remedies are case-by-case backpay orders, posting requirements, election re-runs, etc.). 1 case · 1 ULP

Case numberTypeFiledClosedStatusRegion
20-CA-082896Unfair labor practiceJun 2012Aug 2012ClosedRegion 20, San Francisco, California

Source: NLRB case files. Rows shown are those the agency has published. Region numbers (1–31) correspond to NLRB's geographic offices.

Visa & labor certification (OFLC) — historical

Total applications
394
Certified
377
Denied
1
Avg wage ratio
1.01x
H-1BH-1B1 Singapore

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.

Environmental compliance (EPA)

EPA inspections
23
Quarters non-compliant
0

EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: No Violation Identified.

EPA-registered facilities

Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 9 facilities · 2 marked inactive.

FacilityPermitsStatusInspectionsFormal actionsPenaltiesLast inspectedECHO
GILEAD SCIENCES INC
353 LAKESIDE DRIVE · FOSTER CITY, CA, 94404
RCRANo Violation Identified190Mar 2025View →
GILEAD SCIENCES INC
320, 324, 342, 344, 362 LAKES · FOSTER CITY, CA, 94404
RCRANo Violation Identified30Jan 2025View →
GILEAD SCIENCES INC
351 FOSTER CITY BLVD · FOSTER CITY, CA, 94404
RCRANo Violation Identified10Sep 2022View →
GILEAD SCIENCES INC
355 LAKESIDE DR · FOSTER CITY, CA, 94404
RCRANo Violation Identified00View →
GILEAD SCIENCES INC
1165 CHESS DR · FOSTER CITY, CA, 94404
RCRANo Violation Identified00View →
GILEAD SCIENCES INC
365 FOSTER CITY BLVD · FOSTER CITY, CA, 94404
RCRANo Violation Identified00View →
GILEAD SCIENCES, INC
324 LAKESIDE DR · FOSTER CITY, CA, 94404
RCRANo Violation Identified00View →
GILEAD SCIENCES, INC.
1155 CHESS DRIVE · SAN MATEO, CA, 94404
RCRANo Violation Identified00View →
GILEAD SCIENCES, INC.
353 VINTAGE PARKWAY · FOSTER CITY, CA, 94404
RCRANo Violation Identified00View →

Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.

Federal criminal prosecution record

No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for GILEAD SCIENCES. Verify directly with UVA Corporate Prosecution Registry

Federal contracts

This location

Obligated (5-yr)
$-13956015.54
Obligated (all-time)
$15.2M
Awards
96
Top agency
Department of Veterans Affairs
$9.8M
Company-wide — GILEAD SCIENCES INC (across 4 entities)
Obligated (5-yr)
$-13956015.54
Obligated (all-time)
$15.6M
Awards (all-time)
242

Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.

Top agencies by obligation (this location)
Department of Veterans Affairs$9.8M
Department of Health and Human Services$5.3M
Department of Defense$80K
Largest awards (top 50 of 96)
  • Department of Health and Human Services
    DELIVERY ORDER FOR VEKLURY (REMDESIVIR) FOR THE NSSC CUSTOMERS.
    contract · Last action 2021-02-23
    $3,892,500
  • Department of Health and Human Services
    OFFICE OF INFECTIOUS DISEASE AND HIV/AIDS POLICY (OIDP): ENDING THE HIV EPIDEMIC - PRE-EXPOSURE PROPHYLAXIS (PREP) IMPLEMENTATION AND DISSEMINATION SERVICES
    contract · Last action 2025-09-30
    $1,402,138
  • Department of Veterans Affairs
    YESCARTA PHARMACEUTICAL
    contract · Last action 2022-07-08
    $393,105
  • Department of Veterans Affairs
    YESCARTA
    contract · Last action 2023-10-05
    $307,511
  • Department of Veterans Affairs
    COVID - GILEAD REMDESIVIR (VEKLURY) DRUG FOR INJECTIONS
    contract · Last action 2020-12-24
    $291,938
  • Department of Veterans Affairs
    EMERGENCY DRUG YESCART
    contract · Last action 2022-08-05
    $287,923
  • Department of Veterans Affairs
    YESCARTA TREATMENT.
    contract · Last action 2021-09-24
    $284,905
  • Department of Veterans Affairs
    YESCARTA EMERGENCY NDC 71287-0119-01
    contract · Last action 2021-07-29
    $284,905
  • Department of Veterans Affairs
    TESCARTA CAR T CELL EMERGENCY TRANSPLANT
    contract · Last action 2021-06-01
    $284,905
  • Department of Veterans Affairs
    YESCARTA CAR T CELL
    contract · Last action 2021-04-26
    $284,905
  • Department of Veterans Affairs
    TISCARTA CAR T CELL CANCER TRANSPLANT DRUG NDC 71287-0119-01 EMERGENCY
    contract · Last action 2021-03-16
    $284,905
  • Department of Veterans Affairs
    EMERGENCY TECARTUS CANCER TREATMENT
    contract · Last action 2021-02-02
    $284,905
  • Department of Veterans Affairs
    TECARTUS INFUSION BAG
    contract · Last action 2021-01-15
    $284,905
  • Department of Veterans Affairs
    YESCARTA CAR T CELL THERAPY FOR PT AT NASHVILLE VAMC
    contract · Last action 2020-11-06
    $284,905
  • Department of Veterans Affairs
    PHARMACEUTICAL MEDICATION - YESCARTA
    contract · Last action 2020-10-14
    $284,905
  • Department of Veterans Affairs
    **EMERGENCY**YESCARTA-KITE MEDICATION
    contract · Last action 2020-03-30
    $284,905
  • Department of Veterans Affairs
    YESCARTA
    contract · Last action 2019-05-20
    $284,905
  • Department of Veterans Affairs
    YESCARTA
    contract · Last action 2019-05-20
    $284,905
  • Department of Veterans Affairs
    EMERGENCY- YESCARTA MEDICATION FOR DIRECT PATIENT CARE
    contract · Last action 2019-04-24
    $284,905
  • Department of Veterans Affairs
    PHARMACEUTICAL MEDICATION - YESCARTA
    contract · Last action 2019-03-01
    $284,905
  • Department of Veterans Affairs
    YESCARTA
    contract · Last action 2018-12-26
    $284,905
  • Department of Veterans Affairs
    YESCARTATM AXICABTAGENE CILOLEUCEL INJ,SUSP NATIONAL DRUG CODE (NDC):71287-0119-01
    contract · Last action 2019-07-16
    $284,902
  • Department of Veterans Affairs
    LETAIRIS 5 AND 10 MG. TABLETS
    contract · Last action 2019-12-05
    $273,701
  • Department of Veterans Affairs
    REMDESIVIR 100MG SOLID
    contract · Last action 2020-12-04
    $233,550
  • Department of Veterans Affairs
    REMDESIVIR FOR COVID-19 TREATMENT
    contract · Last action 2021-01-11
    $194,625
  • Department of Veterans Affairs
    REMDESIVIR EMERGENCY PROCUREMENT.
    contract · Last action 2020-12-14
    $194,625
  • Department of Veterans Affairs
    REMDESIVIR 100MG LYOPHILIZED SOLID (COVID-19)
    contract · Last action 2020-11-03
    $194,625
  • Department of Veterans Affairs
    INV-REMDESIVIR 100MG (COVID-19)
    contract · Last action 2020-11-10
    $175,163
  • Department of Veterans Affairs
    REMDESIVIR
    contract · Last action 2021-10-12
    $155,700
  • Department of Veterans Affairs
    COVID EMERGENCY REMDESIVIR FOR INJECTIONS
    contract · Last action 2021-01-06
    $155,700
  • Department of Veterans Affairs
    INV-REMDESIVIR 100MG (COVID-19)
    contract · Last action 2020-11-03
    $155,700
  • Department of Veterans Affairs
    REMDESIVIR 100MG/VIAL INJ
    contract · Last action 2020-12-03
    $140,130
  • Department of Veterans Affairs
    REMDESIVIR
    contract · Last action 2021-01-19
    $136,238
  • Department of Veterans Affairs
    LETAIRIS TABLETS
    contract · Last action 2018-02-20
    $130,900
  • Department of Veterans Affairs
    100MG REMDESIVIR LYOPHILIZED SOLID
    contract · Last action 2020-11-25
    $116,775
  • Department of Veterans Affairs
    EMERGENCY SUPPLY - VEKLURY REMDESIVIR 437
    contract · Last action 2020-11-05
    $89,917
  • Department of Veterans Affairs
    COVID-19 EMERGENCY VEKLURY REMDESIVIR - CI
    contract · Last action 2023-02-06
    $81,743
  • Department of Veterans Affairs
    VEKLURY (REMDESIVIR)
    contract · Last action 2021-03-02
    $77,850
  • Department of Veterans Affairs
    VEKLURY REMDESIVIR 100MG
    contract · Last action 2021-01-21
    $77,850
  • Department of Veterans Affairs
    EMERGENCY PHARMACY ORDER FOR REMDESIVIR
    contract · Last action 2021-01-08
    $77,850
  • Department of Veterans Affairs
    VEKLURY (REMDESIVIR) 100MG LYPH PWD 20ML SDV
    contract · Last action 2020-12-23
    $77,850
  • Department of Veterans Affairs
    REMDESIVIR - 100MG
    contract · Last action 2020-12-16
    $77,850
  • Department of Veterans Affairs
    LETAIRIS 5MG AND 10MG TABS
    contract · Last action 2020-03-03
    $74,375
  • Department of Veterans Affairs
    LETAIRIS 5MG AND 10MG TABLETS
    contract · Last action 2019-04-07
    $74,375
  • Department of Veterans Affairs
    BULK FUNDING FOR FY-17 - DRUG: AMBRISENTAN 5MG TABS (LETAIRIS)
    contract · Last action 2017-12-06
    $71,400
  • Department of Veterans Affairs
    IGF::OT::IGF PHARMACY PATIENT DELIVERY OF LETAIRIS
    contract · Last action 2016-05-18
    $71,400
  • Department of Veterans Affairs
    EO14042 COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER
    contract · Last action 2020-12-23
    $67,730
  • Department of Veterans Affairs
    REMDESIVIR 5MG/ML INJECTION POWDER
    contract · Last action 2022-04-08
    $62,280
  • Department of Veterans Affairs
    EMERGENCY PROCUREMENT FOR REMDESIVIR.
    contract · Last action 2021-02-08
    $58,388
  • Department of Veterans Affairs
    LENACAPAVIR
    contract · Last action 2024-06-26
    $47,797

Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-04-20. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.

Inspection history

DateTriggerViolationsSeriousPenalty
2009-07-30Accident2$0
2007-06-27Unprogrammed Related0$0
2000-01-28Accident32$5,700

Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.

In the news

Part of a larger organization

GILEAD SCIENCES is one of 5 establishments rolled up under the parent organization GILEAD SCIENCES, INC.

Federal enforcement records on this page represent activity at this specific establishment only. The full enforcement footprint of GILEAD SCIENCES, INC across all 5 of its tracked locations is viewable on the parent profile.

Other employers in this industry and state

Other employers in medicinal and botanical manufacturing within CA, ordered by federal enforcement volume:

Other locations under this parent

Other establishments operated by GILEAD SCIENCES, INC, ordered by federal enforcement volume:

Related searches

About this data

This profile aggregates federal enforcement records on GILEAD SCIENCES from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code. This establishment resolves to the parent rollup GILEAD SCIENCES, INC, which operates 5 establishments in our dataset.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

Frequently asked

What is GILEAD SCIENCES's OSHA violation history?
GILEAD SCIENCES has 3 OSHA inspections on record with 5 violations and $5,700 in total penalties.
How does GILEAD SCIENCES's safety record compare to its industry?
GILEAD SCIENCES operates in the medicinal and botanical manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4.